Factors which will influence future compound acquisition
More emphasis on external resources for hit generation?
What can in-house chemistry deliver?
The precision of selection of compounds for specific biological targets will continue to improve
Mapping and occupying drug-like chemical space
Future screening strategies eg throughput?